# Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease

> **NCT02912169** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Ageless Regenerative Institute**

## Conditions studied

- Alzheimer's Disease

## Interventions

- **PROCEDURE:** Liposuction under local anesthesia
- **BIOLOGICAL:** Infusion of AD-SVF via IV and Intranasal

## Key facts

- **NCT ID:** NCT02912169
- **Lead sponsor:** Ageless Regenerative Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-11-01
- **Primary completion:** 2017-11-15
- **Final completion:** 2017-11-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** company dissolved
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02912169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02912169, "Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02912169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*